Literature DB >> 34177214

Metal-binding effects of sirtuin inhibitor sirtinol.

Eman A Akam1, Ritika Gautam1, Elisa Tomat1.   

Abstract

Sirtinol, a Schiff base derived from 2-hydroxy-1-naphthaldehyde, is an inhibitor of sirtuin proteins, a family of deacetylases active in gene regulation and relevant to the study of cancer growth. The formation of copper(II) and zinc(II) complexes of sirtinol is investigated by spectroscopic and structural methods. The molecular structure of this protein inhibitor allows for coordination of first-row transition metals in both tridentate and bidentate fashion. In addition, assays in cultured breast cancer cells reveal that CuII(sirtinol-H)2 and previously reported FeIII(sirtinol-H)(NO3)2 present enhanced cytotoxicity when compared to the free ligand, and that the ferric complex causes an increase in intracellular oxidative stress. Transition metal coordination in the biological milieu could therefore contribute additional effects to the biological profile of sirtinol.

Entities:  

Keywords:  metal chelators; protein inhibitors; sirtinol; sirtuin proteins

Year:  2015        PMID: 34177214      PMCID: PMC8225256          DOI: 10.1080/10610278.2015.1092537

Source DB:  PubMed          Journal:  Supramol Chem        ISSN: 1026-7816            Impact factor:   1.688


  43 in total

1.  What does the commonly used DCF test for oxidative stress really show?

Authors:  Markus Karlsson; Tino Kurz; Ulf T Brunk; Sven E Nilsson; Christina I Frennesson
Journal:  Biochem J       Date:  2010-05-13       Impact factor: 3.857

2.  Histone/protein deacetylase SIRT1 is an anticancer therapeutic target.

Authors:  Bor-Jang Hwang; Amrita Madabushi; Jin Jin; Shiou-Yuh S Lin; A-Lien Lu
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

Review 3.  Seven sirtuins for seven deadly diseases of aging.

Authors:  Brian J Morris
Journal:  Free Radic Biol Med       Date:  2012-10-24       Impact factor: 7.376

4.  Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.

Authors:  Patric J Jansson; Philip C Sharpe; Paul V Bernhardt; Des R Richardson
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

5.  Chemistry: Chemical con artists foil drug discovery.

Authors:  Jonathan Baell; Michael A Walters
Journal:  Nature       Date:  2014-09-25       Impact factor: 49.962

6.  Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.

Authors:  Ho Lee; Kyung Ryoul Kim; Sang Jae Noh; Ho Sung Park; Keun Sang Kwon; Byung-Hyun Park; Sung Hoo Jung; Hyun Jo Youn; Byoung Kil Lee; Myoung Ja Chung; Dai Ha Koh; Woo Sung Moon; Kyu Yun Jang
Journal:  Hum Pathol       Date:  2010-11-05       Impact factor: 3.466

7.  Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.

Authors:  H Ota; E Tokunaga; K Chang; M Hikasa; K Iijima; M Eto; K Kozaki; M Akishita; Y Ouchi; M Kaneki
Journal:  Oncogene       Date:  2006-01-12       Impact factor: 9.867

8.  SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer.

Authors:  Selvakumar Elangovan; Sabarish Ramachandran; Narayanan Venkatesan; Sudha Ananth; Jaya P Gnana-Prakasam; Pamela M Martin; Darren D Browning; Patricia V Schoenlein; Puttur D Prasad; Vadivel Ganapathy; Muthusamy Thangaraju
Journal:  Cancer Res       Date:  2011-09-15       Impact factor: 12.701

Review 9.  Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations.

Authors:  Balaraman Kalyanaraman; Victor Darley-Usmar; Kelvin J A Davies; Phyllis A Dennery; Henry Jay Forman; Matthew B Grisham; Giovanni E Mann; Kevin Moore; L Jackson Roberts; Harry Ischiropoulos
Journal:  Free Radic Biol Med       Date:  2011-10-02       Impact factor: 7.376

10.  Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells.

Authors:  Dante Rotili; Domenico Tarantino; Angela Nebbioso; Chantal Paolini; Covadonga Huidobro; Ester Lara; Paolo Mellini; Alessia Lenoci; Riccardo Pezzi; Giorgia Botta; Maija Lahtela-Kakkonen; Antti Poso; Christian Steinkühler; Paola Gallinari; Ruggero De Maria; Mario Fraga; Manel Esteller; Lucia Altucci; Antonello Mai
Journal:  J Med Chem       Date:  2012-12-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.